Asthma Clinical Trial
Official title:
Improving Asthma Communication in Minority Families
The purpose of this study is to determine if teaching children with asthma how to talk to their doctor about controlling their asthma including symptom frequency in an asthma diary and medication use techniques, will result in less symptom and missed school days, fewer emergency room visits and reduce the cost of asthma health care.
Children with persistent asthma are often not receiving regular preventive asthma care
despite experiencing frequent asthma symptoms. When linked to timely and appropriate asthma
medication use, good physician-parent-child communication is associated with a decrease in
asthma morbidity and mortality. Removing obstacles to preventive asthma care and improving
communication between the parent-children and PCP are two necessary prerequisites to
improving asthma outcomes in low-income minority children.
We, the researchers at Johns Hopkins University, hypothesize that a culturally-tailored
parent and child asthma communication intervention (ACI) designed to teach parent and child
communication skills for use with their health care provider regarding asthma symptom
severity, medication use, personal goal of treatment and quality of life issues will
significantly reduce emergency room utilization for asthma care. We propose to compare this
parent/child asthma communication intervention (ACI) to a developed standard asthma
education intervention (SAE) designed to increase basic asthma self-management.
This study will advance nursing science by improving asthma self-management for school age
children, who may be self-administering their asthma medications, yet not participate in
receiving information or making their own medical decisions regarding their asthma. The
proposed study is targeted at low-income minority school-aged children with evidence of
poorly controlled, high-risk asthma. If successful, this intervention could have significant
practical applications as a component of asthma nurse-case management, to practice currently
being employed by many managed care groups across the country as an intervention for their
high-risk/high ED use asthma patients. Because of the high prevalence and enormous health
impact of asthma and the disproportionate asthma burden experienced by minority children,
the outcome of the proposed study will have significant pediatric nursing applicability.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|